Tania Valencia

Statistics

Publications

Citations

949

H-Index

Active since

2011

Affiliations

Sanford Burnham Prebys Medical Discovery Institute(Current)

Regulus Therapeutics (United States)

The University of Texas Southwestern Medical Center

University of California San Diego

Hutchison/MRC Research Centre

Tania Valencia is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in molecular biology, gene expression, and life sciences.

Publications per year

2011–2023

Publications

Metabolic Reprogramming of Stromal Fibroblasts through p62-mTORC1 Signaling Promotes Inflammation and Tumorigenesis

Tania Valencia, Ji Young Kim, Shadi Abu‐Baker et al. · Cancer Cell · 2014 · 312 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +16

Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease

Edmund C. Lee, Tania Valencia, Charles Allerson et al. · Nature Communications · 2019 · 194 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +17

Adipocyte p62/SQSTM1 Suppresses Tumorigenesis through Opposite Regulations of Metabolism in Adipose Tissue and Tumor

Jianfeng Huang, Ángeles Durán, Miguel Reina‐Campos et al. · Cancer Cell · 2018 · 116 citations · Full text

Life Sciences, Biochemistry, Cancer Biology +16

ATF4-Induced Metabolic Reprograming Is a Synthetic Vulnerability of the p62-Deficient Tumor Stroma

Juan F. Linares, Thekla Cordes, Ángeles Durán et al. · Cell Metabolism · 2017 · 113 citations · Full text

Medicine, Cancer Biology, Molecular Biology +15

PKD1 and PKD2 mRNA cis-inhibition drives polycystic kidney disease progression

Ronak Lakhia, Harini Ramalingam, Chun-Mien Chang et al. · Nature Communications · 2022 · 74 citations · Full text

Medicine, Genetics, Molecular Genetics +13

1–5 of 10